Consequences of Pharmaceutical Fraud Settlements: Off-Label Marketing Continues?
Reporter Susan Todd wrote a fine article in the June 6, 2010 Star –Ledger about off-label marketing. “There are very few companies that haven’t had…
Read More »Pharma 101 – Pharmaceutical Fraud
Pharmaceutical Fraud News & Insight form the Qui Tam and False Claims Act Perspective
Contact FormTag Archives: Unapproved uses
Purdue Pharma Agrees to $19.5 Million Settlement Over Off Label Marketing of OxyContin
Purdue Pharma has agreed to settle claims by 26 states and the District of Columbia for marketing and promoting OxyContin for unapproved uses i.e. for…
Read More »Eli Lilly and Company in More Hot Water
Montana is the latest state to sue Eli Lilly and Company, alleging that the company improperly and fraudulently marketed Zyprexa, an antipsychotic drug for unapproved…
Read More »